4/29/2025InnoCare's Orelabrutinib Receives NMPA Approval as First-Line Therapy ...

4/29/2025Hengrui Secures Approval for Hong Kong IPO

4/29/2025China NMPA Suspends Digoxin API Imports from VITAL LABS

4/29/2025China's Hospital Drug Market Shows Slight Growth in 2024, Driven by On...

4/29/2025Frontera's Gene Therapy FT-017 Achieves Dual Regulatory Clearance in U...

4/29/2025JW and Juno Forge sLVV Licensing Agreement to Advance Cell Therapy Man...

4/29/2025XellSmart Receives NMPA Approval for Landmark Trial of "On-Demand" iP...

4/29/2025CentyMed's Novel EGFR/CD3 BsAb CMDE005 Receives FDA Green Light for Cl...

4/29/2025Ribo Life Science Files for IPO on HKSE, Backed by CICC and Citi

4/29/2025PegBio Poised for IPO on Hong Kong Stock Exchange Following Successful...

4/29/20253SBio Advances Novel MUC17-Targeting Therapy SSS59 into Global Phase 1...

4/29/2025Innovent Initiates Global Phase 1 Trial for ADC IBI3020

4/29/2025DualityBio and AstraZeneca Unite to Investigate Novel Lung Cancer Comb...

4/29/2025Qyuns Sets Up Newco for Global Rights to Its Novel Long-Acting BsAb QX...

4/29/2025Akeso's BsAb Shows Promising Survival Benefit in Lung Cancer Trial

4/26/2025Recent Executive Moves

4/25/2025China's Innovative Drug Licensing Deals Soar, Big Pharma Leads the Buy...

4/25/2025China Greenlights Recordati's Long-Acting Pasireotide for Uncontrolled...

4/25/2025Akeso's Ivonescimab Gains Second Approval in China

4/25/2025Akeso's Penpulimab Secures FDA Approval for Nasopharyngeal Carcinoma

4/25/2025NMPA Approves Expanded Use of JNJ's Rybrevant for Advanced EGFR-Mutate...

4/25/2025China's Fast-Track Drug Approvals Accelerating Access to Novel Therapi...

4/25/2025AstraZeneca China Announces Major Reorganization to Bolster Biopharma ...

4/25/2025JIBP Aims for Hong Kong IPO amid Biopharma Market Revival

4/24/2025Akeso's Ivonescimab Outperforms Tislelizumab in Phase III Trial for sq...

4/24/2025LTZ Thera Secures $40M in Oversubscribed Series A+ to Advance FIC Im...

4/24/2025Merck's Gardasil Sales Plunge Amid China Market Turbulence

4/24/2025Bayer Pharma Accelerates Growth in China with Breakthru Therapies and ...

4/24/2025Ascletis Challenges Lilly, Novo With Promising Oral GLP-1 Data

4/23/2025Global Pharma Feels 'Sense of Urgency' to De-Risk from China Amid Risi...

Page:16/54 Total number of articles:1606: [First][<<] [14] [15] [16] [17] [18] [>>] [End]